These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27263488)

  • 1. Prevalence of hypercalcemia among cancer patients in the United States.
    Gastanaga VM; Schwartzberg LS; Jain RK; Pirolli M; Quach D; Quigley JM; Mu G; Scott Stryker W; Liede A
    Cancer Med; 2016 Aug; 5(8):2091-100. PubMed ID: 27263488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hypercalcemia of malignancy among cancer patients in the UK: analysis of the Clinical Practice Research Datalink database.
    Jick S; Li L; Gastanaga VM; Liede A
    Cancer Epidemiol; 2015 Dec; 39(6):901-7. PubMed ID: 26520619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients.
    Bao L; Wang Y; Lu M; Chu B; Shi L; Gao S; Fang L; Xiang Q
    Cancer Med; 2020 Dec; 9(23):8962-8969. PubMed ID: 33145966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis.
    Bhandari S; Kumar R; Tripathi P; Chan A; Mudra S; Redman R
    Med Oncol; 2019 Sep; 36(10):90. PubMed ID: 31529163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a 24-hour infusion of etidronate disodium for the treatment of hypercalcemia of malignancy.
    Flores JF; Rude RK; Chapman RA; Belani CP; Chang AY; Pritchard JD; Hoff JV
    Cancer; 1994 May; 73(10):2527-34. PubMed ID: 8174049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hypercalcemia of malignancy among pediatric cancer patients in the UK Clinical Practice Research Datalink database.
    Jick S; Li L; Gastanaga VM; Liede A; Hernandez RK
    Clin Epidemiol; 2017; 9():339-343. PubMed ID: 28670142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitriol Elevation Is Associated with a Higher Risk of Refractory Hypercalcemia of Malignancy in Solid Tumors.
    Chukir T; Liu Y; Hoffman K; Bilezikian JP; Farooki A
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1115-23. PubMed ID: 31841590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States.
    Hernandez RK; Wade SW; Reich A; Pirolli M; Liede A; Lyman GH
    BMC Cancer; 2018 Jan; 18(1):44. PubMed ID: 29306325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis on survival and prognostic factors for cancer patients with malignancy-associated hypercalcemia.
    Zhang SJ; Hu Y; Cao J; Qian HL; Jiao SC; Liu ZF; Tao HT; Han L
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6715-9. PubMed ID: 24377594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
    McMahan J; Linneman T
    Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical analysis of 64 patients with lung-cancer-associated hypercalcemia.
    Li X; Bie Z; Zhang Z; Li Y; Hu X; Liu W; Zhang S; Cheng G; Ai B
    J Cancer Res Ther; 2015 Nov; 11 Suppl():C275-9. PubMed ID: 26612452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a randomized multicentric comparison to pamidronate.
    Pecherstorfer M; Steinhauer EU; Rizzoli R; Wetterwald M; Bergström B
    Support Care Cancer; 2003 Aug; 11(8):539-47. PubMed ID: 12783289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center.
    Vassilopoulou-Sellin R; Newman BM; Taylor SH; Guinee VF
    Cancer; 1993 Feb; 71(4):1309-12. PubMed ID: 8382106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcemia in the nephrology department patients - incidence, etiology and impact on renal function.
    Królewicz K; Steć Z; Niemczyk S
    Pol Merkur Lekarski; 2021 Feb; 49(289):9-12. PubMed ID: 33713085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium levels on admission and before discharge are associated with mortality risk in hospitalized patients.
    Akirov A; Gorshtein A; Shraga-Slutzky I; Shimon I
    Endocrine; 2017 Aug; 57(2):344-351. PubMed ID: 28667379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of hypercalcemia of malignancy.
    Solimando DA
    Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S4-7. PubMed ID: 11757205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease.
    Diel IJ; Body JJ; Stopeck AT; Vadhan-Raj S; Spencer A; Steger G; von Moos R; Goldwasser F; Feng A; Braun A
    Eur J Cancer; 2015 Jul; 51(11):1467-75. PubMed ID: 25976743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Diagnostic Workup and Etiology of Hypercalcemia of Malignancy in a Cohort of 167 551 Patients Over 20 Years.
    Sheehan MT; Li YH; Doi SA; Onitilo AA
    J Endocr Soc; 2021 Nov; 5(11):bvab157. PubMed ID: 34703961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy.
    Kawada K; Minami H; Okabe K; Watanabe T; Inoue K; Sawamura M; Yagi Y; Sasaki T; Takashima S
    Jpn J Clin Oncol; 2005 Jan; 35(1):28-33. PubMed ID: 15681601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.